Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. - Wikidata - wikimedia - TriplyDB

Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.

Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.

http://www.wikidata.org/entity/Q37332710

about

Mild cognitive impairment: pathology and mechanisms.Chocolate, Air Pollution and Children's Neuroprotection: What Cognition Tools should be at Hand to Evaluate Interventions?Nutrients, Microglia Aging, and Brain Aging Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders Network dysfunction in Alzheimer's disease: refining the disconnection hypothesis Neuropathological alterations in Alzheimer disease Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease Cognitive and social lifestyle: links with neuropathology and cognition in late life Role of family history for Alzheimer biomarker abnormalities in the adult children study Buying time: a rationale for examining the use of circadian rhythm and sleep interventions to delay progression of mild cognitive impairment to Alzheimer's disease Aggregate-depleted brain fails to induce Aβ deposition in a mouse model of Alzheimer's disease Biochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's disease Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network Development of a small D-enantiomeric Alzheimer's amyloid-β binding peptide ligand for future in vivo imaging applications PET amyloid-beta imaging in preclinical Alzheimer's disease Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia.Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study.Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease.Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease The role of hippocampal iron concentration and hippocampal volume in age-related differences in memory.Pathological correlates of white matter hyperintensities on magnetic resonance imaging.Phosphorylated tau-Aβ42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluid.Oxidative stress and mitochondrial dysfunction in Alzheimer's disease.Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease Increased matrix metalloproteinase 9 activity in mild cognitive impairment.Multimodal techniques for diagnosis and prognosis of Alzheimer's disease Pericellular innervation of neurons expressing abnormally hyperphosphorylated tau in the hippocampal formation of Alzheimer's disease patients.BACE1 and BACE2 enzymatic activities in Alzheimer's disease.APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.Brains from non-Alzheimer's individuals containing amyloid deposits accelerate Aβ deposition in vivo Modulators of cytoskeletal reorganization in CA1 hippocampal neurons show increased expression in patients at mid-stage Alzheimer's disease.Quantitative structural MRI for early detection of Alzheimer's disease.Cerebrospinal fluid biomarkers of Alzheimer's disease.Repair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer's disease.Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease.Effects of healthy aging and early stage dementia of the Alzheimer's type on components of response time distributions in three attention tasks The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders Midlife predictors of Alzheimer's disease.

P2860

Q24631255-CEB89135-8C86-4596-B829-9BE454FF4185 Q26738827-928B975B-ED12-46A9-8535-CEE565A80CD2 Q26768461-B4A76746-ADC1-4223-8188-B906AC872099 Q26850298-75041928-D649-4347-B918-759E39F74A11 Q26995432-F4404584-DA6B-418E-A9AF-64C108CC8ED0 Q27003314-52E29FA8-4577-4477-959E-7340D2DCAE8A Q27003841-1F2515FD-3D56-4459-BF5E-7B75775AD39D Q28304421-2071BC3E-2E94-4DC7-8758-315253ADBCE0 Q28383467-6D4D2039-6DAB-4B48-9CC4-E375AA31135C Q28383805-AF6B374C-14E2-4E3F-9167-FC06291FC7FF Q28539753-B3948CAA-1571-46C8-8EC0-C52E4CA4D903 Q28542628-E2867108-F59E-4083-9820-2DC6ABF4A2E8 Q28714253-B04D4B0D-02BB-4772-B646-5641FE533191 Q28728851-5A8728C9-8374-4B29-9798-2AFBA63201FB Q30040695-B02E49DE-65F4-4A77-AFD0-E487F5A1AFFA Q30413904-279BF119-6BBD-4752-9E4C-78DF73FD2B0E Q30422060-75855D6A-75D1-4331-8691-F973BD3F04A0 Q30426091-E996FF01-2D66-4480-A375-DCE1DACD96B8 Q30497749-CD269DDC-2686-4591-B5F5-C4165C34D794 Q30540311-E9161B28-1F24-4AA9-BE2A-B2C8332449D3 Q30870116-626EBB12-F025-451D-8974-085E31D95744 Q33554802-4840FF84-E2B9-4A6F-B1DB-2D585A7F1B9E Q33555956-E5ACFCAE-93FB-485E-B061-6746445593AD Q33560183-922DA133-0222-4D29-AF92-1EB141C278BF Q33605481-B401C800-5D1B-441E-A5FC-5D7B35CAC62E Q33607535-C809F721-C88E-40FD-B34C-751AEA884481 Q33633043-16732BCF-641C-4111-BEFA-735D0DF90DB2 Q33643141-94587921-0762-422B-A203-4AF5717F6339 Q33695738-33C53D22-79BE-409B-B0EA-41737D8511DB Q33715557-1F282AE4-721A-4258-A8B1-B71AB380C46C Q33725484-2CE3484F-543C-4BE4-90B7-EC8D78F6E3B1 Q33729033-B540CEE1-E9F2-4036-9076-0227D67D6F1B Q33757828-52802159-B00A-4624-B724-E0AA486A9136 Q33769079-9DE0CB83-A077-4D42-A0CC-C2CFD18ABFC8 Q33830572-27A07859-752F-44C0-A1FE-A290218B2C7D Q33831263-435CD42B-7D00-484B-956E-E2EA05665537 Q33902744-48C40375-6C94-44A8-ACE8-9F4196F30B66 Q33912803-F9DC2969-239C-49E9-9DA8-475299CC331D Q33920251-D2CFA6E0-81B7-4E40-A99A-2DD53A979A7F Q33956934-F4624DAE-9516-48C5-9DD0-1B468492DFAA

P2860

Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.

http://www.wikidata.org/entity/Q37332710

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Neuropathology of nondemented ...... preclinical Alzheimer disease.

@en

Neuropathology of nondemented ...... preclinical Alzheimer disease.

@nl

type

label

Neuropathology of nondemented ...... preclinical Alzheimer disease.

@en

Neuropathology of nondemented ...... preclinical Alzheimer disease.

@nl

prefLabel

Neuropathology of nondemented ...... preclinical Alzheimer disease.

@en

Neuropathology of nondemented ...... preclinical Alzheimer disease.

@nl

P1433

Q37332710-F0E54CF5-E85C-4058-BCC2-5BB4FE4B0795

P1476

Q37332710-8883BA1C-8511-4F60-AF33-11ABF2F4CCD4

P2093

Q37332710-042ACE40-92D5-4678-8C85-D4C19571712B

Q37332710-09D5E542-F084-454C-8F07-D6FA7031F698

Q37332710-0A0AC690-E126-47CD-BC87-23DA1CAA12BE

Q37332710-168D493C-64A6-4CE8-B6C4-5B6B2B1974C1

Q37332710-486C309D-88EA-4474-8D22-DC95E1B47AB4

Q37332710-519478D4-A2EE-4773-9DFF-76B863224B73

Q37332710-7A9D6A68-0EA6-45AD-BA31-8042331B0A83

Q37332710-8B34767D-75F4-4041-B001-CD748EE6A903

Q37332710-8F53A688-2FE4-48AC-BC44-AF49C6DCAB62

Q37332710-93394D6A-FE35-4891-9463-C2F9FEA63AC8

P2860

Q37332710-0064F91F-6B9B-44C0-84EB-0D37ED0BF93D

Q37332710-02A18868-69D9-4C38-A095-85F96224B1C8

Q37332710-0AAC0DFE-7A85-4B53-BFE0-21B38870992B

Q37332710-0BAC1351-EB19-4331-A463-923D06D41F0B

Q37332710-1054C690-5BEF-4975-9A65-528802FCF373

Q37332710-1404A762-4237-4021-9ADE-B5EF0EA68727

Q37332710-1A6A66F0-A9E7-4806-9DEC-B1A430348836

Q37332710-1B5CA9C9-346D-4007-A845-17D0ABCCB8AD

Q37332710-1D4DF570-E826-4ABD-B9E5-DE0C8CF4D84A

Q37332710-22461C0F-EED2-4C47-982E-AC434F2EAA42

P304

Q37332710-2251DE38-0D74-4D38-ACD3-7C595B1186B1

P31

Q37332710-F49658CD-73BD-430B-BF2E-68CC61391B55

P356

Q37332710-CC111AD8-D2AA-4157-810D-991D86CC74D8

P433

Q37332710-038B3103-8BCF-432A-B782-4FA29DA50927

P478

Q37332710-BFFFAE4F-FF14-4EDB-89E4-9DBC23A35308

P50

Q37332710-2FE5FFC6-005A-4DD7-9CA5-FD3456DEFF0E

Q37332710-37EDB83D-8F20-4174-A61C-C3F2415BA1CB

Q37332710-748CA4DD-00AB-4D5C-A82D-5C447844D28A

Q37332710-90410C0C-FA37-4C66-A55F-AE9939977008

Q37332710-A113D521-88B5-4E71-8B90-347C914261C0

Q37332710-D883B2A2-09FD-48DE-9ECE-2A5CA0E8B40E

P577

Q37332710-3541B5BA-388D-454B-A647-5706615E5FCF

P5875

Q37332710-F8709CBA-26B9-4206-B449-7F467EF24910

P698

Q37332710-FB3BDE93-BB9F-4D4B-8EE1-B7718CE74DA5

P921

Q37332710-478826C9-35EF-400C-999D-9DFAFEE4E3EA

P932

Q37332710-2E6C77A9-9EAB-443B-BD96-649F8BEB74A3

P356

J.NEUROBIOLAGING.2009.04.002

P1433

Neurobiology of Aging

P1476

Neuropathology of nondemented ...... preclinical Alzheimer disease.

@en

P2093

Catherine M Roe

http://www.w3.org/2001/XMLSchema#string

Charles D Smith

http://www.w3.org/2001/XMLSchema#string

Chengjie Xiong

http://www.w3.org/2001/XMLSchema#string

Christine Hulette

http://www.w3.org/2001/XMLSchema#string

Daniel W McKeel

http://www.w3.org/2001/XMLSchema#string

Daron G Davis

http://www.w3.org/2001/XMLSchema#string

Frederick A Schmitt

http://www.w3.org/2001/XMLSchema#string

Joseph E Parisi

http://www.w3.org/2001/XMLSchema#string

Joseph L Price

http://www.w3.org/2001/XMLSchema#string

Lawrence A Hansen

http://www.w3.org/2001/XMLSchema#string

P2860

Cognitive Reserve and Alzheimer Disease

Alzheimer Disease in the US Population

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

“Mini-mental state”

Neuropathological stageing of Alzheimer-related changes

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

The Clinical Dementia Rating (CDR): current version and scoring rules

Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset.

P304

1026-1036

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROBIOLAGING.2009.04.002

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Dennis W. Dickson

Walter A. Kukull

Ronald C. Petersen

P577

2009-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24307621

http://www.w3.org/2001/XMLSchema#string

P698

19376612

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2737680

http://www.w3.org/2001/XMLSchema#string